Remission achieved in chronic nephropathy by a multidrug approach targeted at urinary protein excretion

Nephron

Volumn 88, Issue 3, 2001, Pages 254-259

  Ruggenenti, Piero ^a,b   Brenner, Barry M ^c   Remuzzi, Giuseppe ^a,b  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b OSPEDALI RIUNITI   (Italy)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Chronic nephropathy; Multidrug approach; Remission; Urinary protein excretion

Indexed keywords

AZATHIOPRINE; ENALAPRIL; METHYLPREDNISOLONE; PREDNISONE;

ADAPTATION; ADULT; ARTICLE; BLOOD PRESSURE REGULATION; CASE REPORT; CHRONIC KIDNEY DISEASE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; KIDNEY PARENCHYMA; PREDICTION; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; REMISSION; SODIUM INTAKE; URINARY EXCRETION;

ADULT; ALGORITHMS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DIURETICS; DRUG THERAPY, COMBINATION; ENALAPRIL; FEMALE; HUMANS; HYDROCHLOROTHIAZIDE; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; LOSARTAN; LUPUS NEPHRITIS; PROTEINURIA; RECEPTORS, ANGIOTENSIN; SODIUM CHLORIDE SYMPORTER INHIBITORS;

EID: 0034930898     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000045998     Document Type: Article

References (21)

1. Pathophysiology of progressive nephropathies
2. Dietary protein intake and the progressive nature of kidney disease: The role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease
3. Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies
4. Blood pressure control, proteinuria, and the progression of renal disease
5. Selective effect of low protein diets in chronic renal diseases
6. Short-term antiproteinuric response to antihypertensive therapy predicts long-term GFR decline in patients with non-diabetic renal disease
7. Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment
8. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy
9. Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN Follow-Up Trial
10. In chronic nephropathies prolonged ACE inhibition can induce remission: Dynamics of time-dependent changes in GFR
11. Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria
12. The effect of angiotensin converting enzyme inhibition on diabetic nephropathy
13. Evidence for regression in animal models
14. ACE inhibition induces regression of proteinuria and halts progression of renal damage in a genetic model of progressive nephropathy
15. Renoprotective therapy: Titration against urinary protein excretion
16. The blunting of the antiproteinuric efficacy of ACE inhibition by high sodium intake can be restored by hydrochlorothiazide
17. ACE inhibition and ANG II receptor blockade improve glomerular size-selectivity in IgA nephropathy
18. The antiproteinuric effect of angiotensin antagonism in human IgA is potentiated by indomethacin
19. Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy (abstract)
20. Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathy
21. Novel strategies to retard renal disease progression: Combining ACE inhibition with endothelin receptor blocking?